Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock

Condition(s) studied

Study summary

This large real-world international prospective registry will provide a unique opportunity to comprehensively understand the contemporary management, clinical course and short as well as long-term outcomes of all Cardiogenic Shock (CS) patients cared for at four high volume dedicated shock care centers. As the first true North American multicenter CS collaborative with a uniform dedicated and comprehensive case report form, the high patient volumes and wide spectrum of clinical acuity seen at these institutions will provide valuable insight into the factors associated with adverse outcomes; and will serve as a blueprint for future clinical trial designs that may better inform clinical practice.

Eligibility

Primary outcome measure(s)

• Survival — 1 year
  Percentage of participants alive at analysis time points

Trial sites (3)

Other trials for the same condition